Literature DB >> 22294735

NR4A2: effects of an "orphan" receptor on sustained attention in a schizophrenic population.

Inés Ancín1, José A Cabranes, Blanca Vázquez-Álvarez, José Luis Santos, Eva Sánchez-Morla, Maaike Alaerts, Jurgen Del-Favero, Ana Barabash.   

Abstract

NR4A2 (nuclear receptor subfamily 4 group A member 2) or Nurr1 is a transcription factor implied in the differentiation, maturation, and survival of dopaminergic neurons. It also has a role in the expression of several proteins that are necessary for the synthesis and regulation of dopamine (DA), such as tyrosine hidroxilase, dopamine transporter, vesicular monoamine transporter 2, and cRET. DA is an important neurotransmitter in attentional pathways. Our aim was to evaluate the influence of NR4A2 gene in the performance of schizophrenia (SZ) patients and healthy subjects on a sustained attention task. For this study, we collected 188 SZ subjects (Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition) and 100 control individuals. We genotyped 5 tag SNPs in NR4A2 gene: rs1150143 (C/G), rs1150144 (A/G), rs834830 (A/G), rs1466408 (T/A), and rs707132 (A/G). We also analyzed the influence of its haplotypes (frequency>5%). To examine sustained attention, all the individuals completed the Degraded Stimulus Continuous Performance Test. We evaluated "hits," "reaction time," "sensibility a," and "false alarms." In the schizophrenic group, recessive genotypes of rs1150143, rs1150144, rs834830, and rs707132 were associated with a worse performance. SZ subjects who carried GGGTG haplotype showed less hits (P<.004), lower sensibility a scores (P<.009), and a higher reaction time (P=.013). We observed a sex effect of the gene: genotype and haplotype associations were only present in the male group. We conclude that NR4A2 gene is involved in attentional deficits of SZ patients, modifying hits, sensibility a, and reaction time.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22294735      PMCID: PMC3627752          DOI: 10.1093/schbul/sbr176

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  39 in total

1.  Identification of Dlk1, Ptpru and Klhl1 as novel Nurr1 target genes in meso-diencephalic dopamine neurons.

Authors:  Frank M J Jacobs; Annemarie J A van der Linden; Yuhui Wang; Lars von Oerthel; Hei Sook Sul; J Peter H Burbach; Marten P Smidt
Journal:  Development       Date:  2009-06-10       Impact factor: 6.868

2.  Reduced tyrosine hydroxylase and GTP cyclohydrolase mRNA expression, tyrosine hydroxylase activity, and associated neurochemical alterations in Nurr1-null heterozygous mice.

Authors:  Jeffrey B Eells; Jaime A Misler; Vera M Nikodem
Journal:  Brain Res Bull       Date:  2006-05-22       Impact factor: 4.077

3.  Rapid increase of Nurr1 mRNA expression in limbic and cortical brain structures related to coping with depression-like behavior in mice.

Authors:  Patricia Rojas; Eliza Joodmardi; Thomas Perlmann; Sven Ove Ogren
Journal:  J Neurosci Res       Date:  2010-08-01       Impact factor: 4.164

4.  NURR1 mutations in cases of schizophrenia and manic-depressive disorder.

Authors:  S Buervenich; A Carmine; M Arvidsson; F Xiang; Z Zhang; O Sydow; E G Jönsson; G C Sedvall; S Leonard; R G Ross; R Freedman; K V Chowdari; V L Nimgaonkar; T Perlmann; M Anvret; L Olson
Journal:  Am J Med Genet       Date:  2000-12-04

5.  Adult mice with reduced Nurr1 expression: an animal model for schizophrenia.

Authors:  P Rojas; E Joodmardi; Y Hong; T Perlmann; S O Ogren
Journal:  Mol Psychiatry       Date:  2007-04-24       Impact factor: 15.992

6.  NURR1 promoter polymorphisms: Parkinson's disease, schizophrenia, and personality traits.

Authors:  Andrea Carmine; Silvia Buervenich; Dagmar Galter; Erik G Jönsson; Göran C Sedvall; Lars Farde; J Petter Gustavsson; Hans Bergman; Kodavali V Chowdari; Vishwajit L Nimgaonkar; Maria Anvret; Olof Sydow; Lars Olson
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2003-07-01       Impact factor: 3.568

7.  Visual sustained attention: image degradation produces rapid sensitivity decrement over time.

Authors:  K H Nuechterlein; R Parasuraman; Q Jiang
Journal:  Science       Date:  1983-04-15       Impact factor: 47.728

8.  Sex differences in the risk of schizophrenia: evidence from meta-analysis.

Authors:  Andre Aleman; René S Kahn; Jean-Paul Selten
Journal:  Arch Gen Psychiatry       Date:  2003-06

9.  Meta-analysis of 32 genome-wide linkage studies of schizophrenia.

Authors:  M Y M Ng; D F Levinson; S V Faraone; B K Suarez; L E DeLisi; T Arinami; B Riley; T Paunio; A E Pulver; P A Holmans; M Escamilla; D B Wildenauer; N M Williams; C Laurent; B J Mowry; L M Brzustowicz; M Maziade; P Sklar; D L Garver; G R Abecasis; B Lerer; M D Fallin; H M D Gurling; P V Gejman; E Lindholm; H W Moises; W Byerley; E M Wijsman; P Forabosco; M T Tsuang; H-G Hwu; Y Okazaki; K S Kendler; B Wormley; A Fanous; D Walsh; F A O'Neill; L Peltonen; G Nestadt; V K Lasseter; K Y Liang; G M Papadimitriou; D G Dikeos; S G Schwab; M J Owen; M C O'Donovan; N Norton; E Hare; H Raventos; H Nicolini; M Albus; W Maier; V L Nimgaonkar; L Terenius; J Mallet; M Jay; S Godard; D Nertney; M Alexander; R R Crowe; J M Silverman; A S Bassett; M-A Roy; C Mérette; C N Pato; M T Pato; J Louw Roos; Y Kohn; D Amann-Zalcenstein; G Kalsi; A McQuillin; D Curtis; J Brynjolfson; T Sigmundsson; H Petursson; A R Sanders; J Duan; E Jazin; M Myles-Worsley; M Karayiorgou; C M Lewis
Journal:  Mol Psychiatry       Date:  2008-12-30       Impact factor: 15.992

10.  Genome scan meta-analysis of schizophrenia and bipolar disorder, part II: Schizophrenia.

Authors:  Cathryn M Lewis; Douglas F Levinson; Lesley H Wise; Lynn E DeLisi; Richard E Straub; Iiris Hovatta; Nigel M Williams; Sibylle G Schwab; Ann E Pulver; Stephen V Faraone; Linda M Brzustowicz; Charles A Kaufmann; David L Garver; Hugh M D Gurling; Eva Lindholm; Hilary Coon; Hans W Moises; William Byerley; Sarah H Shaw; Andrea Mesen; Robin Sherrington; F Anthony O'Neill; Dermot Walsh; Kenneth S Kendler; Jesper Ekelund; Tiina Paunio; Jouko Lönnqvist; Leena Peltonen; Michael C O'Donovan; Michael J Owen; Dieter B Wildenauer; Wolfgang Maier; Gerald Nestadt; Jean-Louis Blouin; Stylianos E Antonarakis; Bryan J Mowry; Jeremy M Silverman; Raymond R Crowe; C Robert Cloninger; Ming T Tsuang; Dolores Malaspina; Jill M Harkavy-Friedman; Dragan M Svrakic; Anne S Bassett; Jennifer Holcomb; Gursharan Kalsi; Andrew McQuillin; Jon Brynjolfson; Thordur Sigmundsson; Hannes Petursson; Elena Jazin; Tomas Zoëga; Tomas Helgason
Journal:  Am J Hum Genet       Date:  2003-06-11       Impact factor: 11.025

View more
  5 in total

Review 1.  Toxoplasma gondii: Biological Parameters of the Connection to Schizophrenia.

Authors:  Jianchun Xiao; Emese Prandovszky; Geetha Kannan; Mikhail V Pletnikov; Faith Dickerson; Emily G Severance; Robert H Yolken
Journal:  Schizophr Bull       Date:  2018-08-20       Impact factor: 9.306

2.  Chronic Toxoplasma gondii in Nurr1-null heterozygous mice exacerbates elevated open field activity.

Authors:  Jeffrey B Eells; Andrea Varela-Stokes; Shirley X Guo-Ross; Evangel Kummari; Holly M Smith; Erin Cox; David S Lindsay
Journal:  PLoS One       Date:  2015-04-09       Impact factor: 3.240

Review 3.  Immediate-Early Genes Modulation by Antipsychotics: Translational Implications for a Putative Gateway to Drug-Induced Long-Term Brain Changes.

Authors:  Andrea de Bartolomeis; Elisabetta F Buonaguro; Gianmarco Latte; Rodolfo Rossi; Federica Marmo; Felice Iasevoli; Carmine Tomasetti
Journal:  Front Behav Neurosci       Date:  2017-12-11       Impact factor: 3.558

4.  Working memory deficits in schizophrenia are associated with the rs34884856 variant and expression levels of the NR4A2 gene in a sample Mexican population: a case control study.

Authors:  Elizabeth Ruiz-Sánchez; Janet Jiménez-Genchi; Yessica M Alcántara-Flores; Carlos J Castañeda-González; Carlos L Aviña-Cervantes; Petra Yescas; María Del Socorro González-Valadez; Nancy Martínez-Rodríguez; Antonio Ríos-Ortiz; Martha González-González; María E López-Navarro; Patricia Rojas
Journal:  BMC Psychiatry       Date:  2021-02-09       Impact factor: 3.630

5.  Arc Regulates Transcription of Genes for Plasticity, Excitability and Alzheimer's Disease.

Authors:  How-Wing Leung; Gabriel Foo; Antonius VanDongen
Journal:  Biomedicines       Date:  2022-08-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.